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STUDIES in vivo on the incorporation of oestrogens by the uteri of immature
rats (Jenson and Jacobson, 1962) and of ovariectomised mice (Stone, 1963), and
on the incorporation of radioactivity by the ventral prostate and seminal vesicles
of the male rat after injection of [14C] testosterone (Greer, 1959) suggest that
steroids may be selectively incorporated by those tissues whose growth is depend-
ent on their presence. Such steroids might also be selectively incorporated by
those breast carcinomas of humans which are influenced by steroids.
Evidence of a link in humans between the " hormone-dependency " of breast
carcinomas and the ability of such carcinomas to incorporate hexoestrol (3,4-bis-
(parahydroxy-phenyl)-n-hexane) was obtained by Folca, Glascock and Irvine
(1961). In those patients who subsequently responded favourably to bilateral
adrenalectomy and oophorectomy there was a selective incorporation of radio-
activity by breast metastases removed 6 hours after intravenous injection of
tritiated hexoestrol. More recently, Desphande, Bulbrook and Ellis (1963)
found that 6 hours after intravenous injection of tritiated testosterone there had
been selective incorporation of radioactivity by the breast carcinoma tissue of
some, but not of other patients. The results of both these experiments suggest
the existence of more than one class of breast carcinoma which differ in their
ability to incorporate steroids. Since 17ac-methyltestosterone (MeT) is used for
treatment of carcinoma of the breast it was thought that a similar investigation
but concerned with the uptake of MeT by breast carcinoma and other tissues
would be of importance. Determination of the concentration of radioactivity
alone in carcinoma and in other tissues, however, does not necessarily permit a
true comparison to be made of the relative amounts of the administered steroid
present in the tissues because radioactive metabolites will almost certainly also
be present. An attempt was made, therefore, to determine not only the total
radioactivity ofthe tissues but also to determine the amount which was associated
with unchanged MeT.
The amount of radioactivity in each tissue was expressed in terms of the wet
weight ofthe tissue, although it is recognised that such a method takes no account
of the many differences in the structures of those tissues which were examined.
A limited study of the rate of incorporation of MeT (and of radioactivity
derived therefrom) by adipose and carcinoma tissues was also undertaken.
MATERIALS
[1,2-3H] MeT
[1,2-3H] MeT was prepared by the partial reduction of 17a-methyl-1773-
hydroxy-androst-1,4-dien-3-one in a tritium/hydrogen mixture with palladiumR. V. QUINCEY AND C. H. GRAY
on charcoal as the catalyst and, after purification, the steroid was diluted with
unlabelled material to a specific activity of 10,uc.1/,ug. (Quincey and Gray, 1966a).
10 sIc. portions of the steroid were sealed in glass ampoules in 0*2 ml. ethanol
and stored at 200 C. Ampoules which had been stored for more than four
months were not used.
The subjects of investigation
Each of the fourteen patients who were studied had an adenocarcinoma of
the breast and all except one were women aged between 38 and 66 years. The
exception was a male aged 67 years.
Clinical details relating to these patients are summarised in Table T.
TABLE I. Clinical Data of Patients in whom the Uptake of [1,2-3H ] MeT
by Tissues Was Studied
Age Lymph node
Patient years Description of adenocarcinoma metastases
F. W. 52 Poorly-differentiated, poorly cellular . present
M. B. . 45 Poorly-differentiated, cellular . present
E. K. 54 . Poorly-differentiated, poorly cellular . present
S. K. . 56 Poorly-differentiated, poorly cellular . present
F. S. . 61 Poorly-differentiated, moderately cellular . absent
L. R. . 57 Poorly-differentiated, poorly cellular absent
W. H. . 53 Poorly-differentiated, cellular . absent
C. C.* 67 . Well-differentiated, cellular absent
V. R. . 47 Moderately well-differentiated, poorly cellular present
A. S. . 38 . Poorly-differentiated, moderately cellular absent
N. C. 57 . Poorly-differentiated, cellular . present
K. N. 66 . Poorly-differentiated, cellular . present
R. B. 55 . Moderately well-differentiated, cellular . absent
B. B. 66 . Well-differentiated, cellular absent
* Male
Silica gel
" M.F.C. " grade (Hopkins & Williams, Ltd.) was refluxed for 1 hour with
concentrated aqueous ammonia to break down metal complexes, washed
thoroughly with water and refluxed for 1 hour with 36N hydrochloric acid. It
was then washed with water, methanol and chloroform and activated by heating
for 16 hours at 1200 C.
Liquid scinttillation phosphors
Two phosphors based respectively on toluene and on dioxan were used;
their composition is described by Gray and Shaw (1965).
Solvents
All solvents were of reagent grade and were redistilled before use.
METHODS
Administration of [1,2-3H] MeT and the collection and storage of samples
Each patient received 10 ,jc. [1,2-3H] MeT. Steroid to be taken orally was
mixed with 5 ml. ethanol, 15 ml. water and 5 ml. of orange juice immediately
before administration. Steroid to be given by intravenous injection was mixed
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with 10 ml. 0.900 NaCl solution and was injected over one minute into the ante-
cubital vein. The syringe was rinsed by collection and re-injection of a few ml.
of blood.
Small pieces (1-3 g.) of adipose tissue, striated muscle, skin dissected free of
subcutaneous fat and of the carcinoma were obtained from the excised tissue and
were blotted, weighed and stored at 20° C. until required. On all occasions
the pieces of tumour tissue were shown by histological examination to be carcino-
matous.
The extraction of radioactive steroids from tissues
The weighed pieces oftissue were cut into thin slices (50-100 m,t) on a freezing
microtome and homogenised for 5 minutes in about 10 ml. methanol (acidified
with glacial acetic acid) in an M.S.E. blender. The methanolic extract was
decanted and the tissue homogenised successively in about 10 ml. of chloroform,
acid methanol and chloroform. The extracts were combined and, after the
addition of 1-0 mg. of unlabelled MeT as a carrier, the solvent was removed by
evaporation.
Column chromatography of steroids extracted from tissues
A procedure for removing fat from the tissue extracts and for fractionating
the steroids and steroid conjugates which might be present in these extracts
was necessary. The column chromatography procedure which was adopted also
permitted some estimate to be made ofthe relative amounts in tissues ofunchanged
MeT and of metabolites of MeT because an effective separation of MeT from
metabolites of MeT was obtained.
A column (0.8 cm. internal diameter) containing 4 g. activated silica gel was
used for the chromatography. Preliminary experiments (Table If) showed that
whilst no MeT could be eluted with 50 ml. dichloromethane, an almost quantitative
elution could be obtained with 50 ml. 0.500 ethanolic chloroform. Dichloro-
methane eluted fat and was used for this purpose in the chromatography. Although
MeT is quantitatively eluted by 50 ml. 0.50/a ethanolic chloroform solution,
metabolites of MeT which have polarities similar to that of MeT may also be
eluted in this fraction. Paper chromatography of metabolites of MeT obtained
from urine showed that no major metabolite was less polar than MeT and that
17a-methyl-5,/-androstane-3a, 17,-diol and 17a-methyl-5a-androstane-3a, 17/3-diol
had polarities similar to that of MeT (Quincey and Gray, 1966b). The chromato-
graphic properties on silica gel of these two metabolites and of the next least
polar metabolite (metabolite L) were investigated. The results, also in Table II,
show that none of these compounds were eluted with 50 ml. dichloromethane and
less than half of 17a-methyl-5,8-androstane-3a, 17,8-diol or of 17a-methyl-5a-
androstane-3x, 17,/-diol and only 300 of metabolite L was eluted with 50 ml.
0*5 0 ethanolic chloroform.
Although some separation of MeT from metabolites was thus achieved, the
radioactivity of the 0-500 ethanolic chloroform fractions obtained from tissues
might not be wholly associated with MeT. However, direct determination of
the composition ofthe 0°5Qo ethanolic chloroform fractions obtained after chroma-
tography of extracts of adipose tissue and carcinoma tissue was attempted on
one occasion, using paper chromatography in the Bush A system (Bush, 1952) to
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TABLE II.-Chromatography of [1,2-3H] MeT and of [1,2-3H] Labelled
Metabolites of MeT on a Silica Gel Column
Metabolites of [1.2-3H] MeT were obtained from extracts of the urine of
two patients to whlom [1,2-3H] MeT of specific activity of4415 ,uc./mg. had
been administered. Microgram amounts ofeach compound were dissolved
in dichloromethane and applied to columns containing 4 g. activated silica
gel.
Elution with 50 ml. of Elution with 50 ml. 0 .5%
dichloromethane ethanolic chloroform.
Compound Recovery of radioactivity Recovery of radioactivity
0o 0
AMeT . 04 94-7
17a-methyl-5a-androstane-3a,177f-dliol 04 . 40 8
17a-methyl-5fl-androstane-3a.17j3-diol 00 . 46- 7
AMetabolite L 00 30
separate [1.2-3H] MeT from otherradioactive steroids, and 58 and 780 respectively
ofthe radioactivity in those fractions was found to be associated with [1,2-3H] MeT.
It was therefore concluded that measurement of the radioactivity of the 0.500
ethanolic chloroform fractions provided a reasonable but high estimate of the
amount of [1,2-3H] MeT in the tissues.
A proportion of the radioactivity in tissues might be expected to be associated
with steroid conjugates which are very polar and it was therefore of importance
to determine if steroid conjugates could be eluted from the silica gel column.
Radioactive steroid conjugates were obtained from the urine of a patient to
whom [1,2-3H] MeT had been given and a few micrograms were applied to a 4 g.
silica gel column. Complete elution of the radioactive steroid conjugates was
obtained with 50 ml. of 100% aqueous ethanol.
The following procedure for the chromatography of radioactive steroids
obtained from tissues was adopted. Each extract was dissolved in dichloro-
methane and applied to the column. Three fractions were obtained by eluting
successively with 50 ml. dichloromethane, 50 ml. 0-500 ethanolic chloroform and
with 50 ml. 10% aqueous ethanol. After each change of solvent the flask which
contained the original extract was washed with the next solvent mixture to be
used and the washings were applied to the column. Solvent was removed from
each 50 ml. fraction by evaporation, and the whole of each residue taken for the
measurement of radioactivity.
In this way the total amount of radioactivity in tissues was determined and
some estimate could be made of the amount which was associated with unchanged
MeT.
Measurement of radioactivity
Each sample was counted at -2° C. for 200 minutes (4 x 50 min.) in a Packard
"Tri-Carb " Automatic Liquid Scintillation Spectrometer (Model No. 314EX).
Extracts containing neutral steroids alone were counted in 15 ml. toluene phosphor
whilst extracts containing steroid conjugates were counted in a solution of 10 ml.
dioxan phosphor and 1*0 ml. of ethanol. Counting efficiency was estimated
using [3H] toluene as an internal standard and in toluene phosphor was 11-6-
29-6% and in dioxan phosphor was 7.4-19.5%.
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Statistical analysis of the results
Although samples of the same tissue from different patients might not belong
to a single population as defined by the ability to incorporate radioactive steroid,
no distinction between such hypothetical types could be made on the basis of
the results which were obtained. The results for each ofthe tissues have.therefore
been treated as though they had arisen from a single tissue population.
The comparison of the results of any two series of tissues was concerned only
with those values from one series for which corresponding values from the other
series were obtained. Thus " within-patient " differences for each of the values
within any two series of tissues were calculated and from these values the mean
difference and thestandarderrorofthe mean of thedifferences were obtained. The
mean difference thus calculated only equals the difference of the means of any
two series when the number of observations within both series equals the number
of observations which may be compared. Values of t were obtained (mean
difference/standard error) and the probabilities of the differences being due to
chance were thus ascertained. Differences between series were regarded as
significant only if P was equal to or less than 0*05.
Failure to observe statistically significant differences might not mean that
differences did not exist because the number of observations which were made
might merely have been insufficient.
RESULTS
A Comparison ofthe Concentrations of MeT and ofMetabolites of MeT and of Total
TissueRadioactivity in Carcinoma and Other Tissues Removed by Mastectomy 6 hours
after Oral Administration of [1,2-3H] MeT
Extracts of tissues from nine patients were examined and the results which
were obtained are shown in Table III. The amount of radioactivity in the
dichloromethane fractions obtained after the column chromatography of extracts
of any of the tissues was very low (7-14 d.p.m./g.) and, in view of the difficulty
of accurately measuring such small amounts of radioactivity in the presence of
various amounts of fat, can be considered to be not significant. The amounts
of radioactivity in the 0.5% ethanolic chloroform and 10% aqueous ethanol
fractions approximately corresponded to that which was associated with MeT
and with metabolites of MeT respectively. Both of these latter fractions con-
tained readily measurable amounts of radioactivity.
Radioactivity of the 0.5% ethanolic chloroform fractions (MeT)
The radioactivity of fractions obtained from extracts of carcinoma tissue
(169 d.p.m./g.) was greater than was obtained from extracts of muscle (124
d.p.m./g.) and from skin (130 d.p.m./g.) but was lower than was obtained from
extracts ofadipose tissue (205 d.p.m./g.). The radioactivity offractions obtained
from adipose tissue was higher than was obtained from the other tissues.
Statistical analysis (Table IV) showed that the differences observed between
adipose tissue and skin (74.4 d.p.m./g.) were significant and that the other differ-
ences which were observed were not significant.
Radioactivity of the 10% aqueous ethanol fractions (metabolites of MeT)
The radioactivity of fractions obtained from extracts of carcinoma tissue
(288 d.p.m./g.) was greater than was obtained from adipose tissue (119 d.p.m./g.),
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muscle (124 d.p.m./g.) and from skin (215 d.p.m./g.). The radioactivity of
fractions obtained from adipose tissue was lower than was obtained from the
other tissues.
Statistical analysis (Table IV) showed that the differences observed between
carcinoma tissue and adipose tissue (169.9 d.p.m./g.), muscle (78.6 d.p.m./g.)
and skin (73.0 d.p.m./g.) were significant. In addition, the difference observed
between skin and adipose tissue (95.8 d.p.m./g.) was also significant, although
the other differences observed were not.
The radioactivity of these fractions must have been wholly associated with
metabolites of MeT because any MeT in the original tissue extracts would have
been removed in the 0.500 ethanolic chloroform eluate.
Total tissue radioactivity
The total radioactivity of extracts of carcinoma tissue (464 d.p.m./g.) was
higher than that of any of the other tissues. Muscle contained the lowest concen-
tration of radioactivity (308 d.p.m./g.) but this was only slightly less than in
adipose tissue (336 d.p.m./g.) and in skin (359 d.p.m./g.).
Statistical analysis (Table IV) showed that the differences observed between
carcinoma tissue and muscle (108.7 d.p.m./g.) were significant and that the
differences of 128-3 and 105-0 d.p.m./g. observed between carcinoma and adipose
tissue and between carcinoma tissue and skin respectively just lacked significance.
None of the other differences were significant.
There was no pronounced selective incorporation of radioactivity by the
carcinoma tissue of the magnitude (3-15 times that of muscle) observed by
Desphande et al. (1963) after administration of radioactive testosterone or by
Folca et al. (1961) after administration of radioactive hexoestrol.
The rate of incorporation of MeT and the rate of appearance of metabolites of MeT
in adipose and carcinoma tissues removed by mastectomy
A full investigation would have involved measuring the radioactivity of a
large number of tissue samples because of the large natural variation in the
radioactivity of the same tissues of different patients. Only a limited study was
possible, and the radioactivity of extracts of adipose and carcinoma tissues
removed 15-210 minutes after intravenous injection of [1,2-3H] MeT was measured
in a series of five patients (A. S., N. C., K. N., R. B. and B. B.). The results
shown in Fig. 1 and 2 include the mean values for 360 minutes obtained in the
previous investigation as any error caused by differences in the method of admini-
stration of the steroid after this period of time (360 minutes) was unlikely to be
greater than those inherent in the experiment. Figs. 1 and 2 also show composite
values (from data ofQuincey and Gray, 1966b) for the radioactivity ofthe unconju-
gated (mainly MeT) and conjugated (metabolites ofMeT) steroid fractions obtained
from the plasma of three subjects at various times after intravenous injection of
10 ,uc. [1,2-3H] MeT. Differences in the methods of estimation and expression
of the results of these experiments preclude any strict comparison of the results
in plasma and tissue.
Although the incorporation of MeT by both adipose and carcinoma tissue was
of a similar magnitude, incorporation by the carcinoma tissue proceeded slightly
more rapidly and reached a maximum after about 60 minutes. The amount of
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MeT in adipose tissue reached a maximum after about 110 minutes. The amount
of MeT in either tissue only equalled the amount in plasma after 90-100 minutes
and then remained at a consistently higher level. The rate of decline in the
amount of MeT in the tissues throughout this last phase was similar to the rate
of decline of MeT in plasma.
The rates of appearance of radioactivity associated with metabolites of MeT
in adipose and carcinoma tissues were similar; in both cases the initial rapid
rise lasted for about 90 minutes and was succeeded by a more gradual rise lasting
for the remainder of the period studied. The extent of the rise in carcinoma
tissue was much greater than in adipose tissue; the final concentration in carci-
noma tissue being about two and a half times greater than in adipose tissue.
The radioactivity associated with metabolites of MeT in both tissues was very
much lower than the amount which was found in plasma. In adipose tissue the
concentration of metabolites of MeT was only one-ninth that of plasma whilst
in carcinoma tissue the concentration was approaching one-third that of plasma.
I)ISCUSSION
The uptake of MeT by breast carcinoma and other tissues has been studied
mainly after oral administration of the steroid. After oral administration, the
steroid passes through the liver where it may be metabolised and only then is it
able to enter the peripheral circulation where it becomes available to the tissues.
Clearance of MeT from blood by metabolism in the liver cannot be rapid, however,
as the half-life (155 minutes) of MeT in blood is large (Quincey and Gray, 1966b).
Absorption of the steroid in the gut was assumed to be complete because the
dose was administered as a solution in aqueous alcohol and was present in only
trace amounts. Moreover, Hyde, Elliott, Doisy and Doisy (1954) have demon-
strated that in rats absorption of orally administered MeT is complete and it has
been shown that in humans the rate of excretion of radioactivity after oral
administration of [1,2-3H] MeT in solution is similar to that observed after intra-
venous injection (Quincey and Gray, 1966b). Thus, oral administration was
considered to be adequate in those instances in which the time interval between
administration and removal of the tissue was large. When this interval was of
short duration, administration by intravenous injection became necessary.
A steroid hormone which acts directly on a particular process in a particular
tissue presumably interacts with receptors which in some way are concerned with
the regulation of that process. The interaction may involve binding of the
steroid to the receptor molecule and this may alter the structure and hence
modify the function of that receptor; or in the particular case of the steroid-
induced transhydrogenases, the steroid may act as a coenzyme or enzyme pros-
thetic group (Dixon, Gray and Quincey, 1964).
Such specific interactions may result in an increased incorporation of the
steroid in the responsive tissue (Harding and Samuels, 1962 ; Bellamy, 1963)
but it is possible that the amount of steroid associated with such receptors may
be small when considered in relation to the amount of steroid present simply
in solution or bound to other non-specific receptors. Thus, differences in the
amounts of a steroid present in different tissues which are due to interactions
with specific functional receptors may be masked by differences caused by non-
specific binding or by the gross structural differences which distinguish one tissue
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from another. Nevertheless, a much increased incorporation of a steroid by a
tissue might indicate the presence in that tissue of specific receptors, particularly
if the gross structure of the tissue was similar to that of the control tissue.
Thus, if control mechanisms in carcinoma tissue were dependent at least in
part on the direct action of steroids, specific functional receptors would be present
which might be detected by measurement of the uptake of such steroids by the
carcinoma and other tissues. The results obtained by Desphande et al. (1963)
and by Folca et al. (1961) have already been alluded to and suggest that the breast
carcinoma tissue of some but not of all patients contained specific receptors
which were not present in the other tissues which were examined. No such
selective incorporation of MeT was observed by the carcinoma tissue of any of
the patients to whom MeT had been administered six hours previously. More-
over, as adipose and carcinoma tissues incorporated radioactivity at similar
rates, it seemed unlikely that selective incorporation could have been demon-
strated at any other time after administration ofthe steroid, although the relative
amounts ofMeT and ofmetabolites ofMeT inthe tissues wouldhave been different.
This does not mean that specific receptors which may bind MeT do not exist in
carcinoma tissue, indeed Kim and Furth (1963) concluded that the effects which
oestrogens have on the growth of mammary carcinoma in rats were secondary
and were caused by oestrogen-induced changes in the secretion of prolactin by
the pituitary.
The concentration ofMeT in carcinoma tissue 6 hours after oral administration
of this steroid was not significantly different from the concentration found in
each of the other tissues, but was greater than in plasma. The concentration of
metabolites of MeT in carcinoma tissue was significantly greater than in each of
the other tissues but was much less than the concentration of metabolites in
plasma. The proportion of the total radioactivity which was present as MeT
in carcinoma tissue (36%) was similar to that found in muscle (40%) and in
skin (36%) but was smaller than MeT in adipose tissue (61%). The high propor-
tion of MeT in adipose tissue probably reflected differences in the relative solu-
bilities in fat ofMeT and ofthe more polar metabolites ofMeT. The appearance
after this time of relatively large amounts of metabolites of MeT, which are
presumably physiologically inert, emphasises the importance in such studies as
these ofachieving someseparationoftheadministeredsteroidfromthemetabolites.
The appearance in the tissues of radioactive metabolites of MeT could be the
result ofin situ metabolism ofMeT or could be due to the passage into the tissues
ofmetabolites formed elsewhere, or might possibly be the result ofboth processes.
It is not possible to distinguish between these possibilities on the basis of the
present investigation but, although the liver is almost certainly quantitatively
the most important site for the metabolism of steroids, extrahepatic metabolism
of androgens is well established (Thomas and Dorfman, 1964a, 1964b; West
and Samuels, 1951; King, Gordon and Smith, 1964; Ryan, 1958).
SUMMARY
The concentration of radioactive MeT and metabolites of MeT in adipose,
muscle, skin and carcinoma tissues which had been removed from patients 6
hours after oral administration of [1,2-3H] MeT was measured on nine occasions.
No evidence was found which might suggest that some breast carcinomas can
selectively incorporate this steroid.
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Although no significant differences were observed between the concentrations
of MeT in the carcinoma and other tissues, the concentration of metabolites of
MeT in carcinoma tissue was significantly higher than in any of the other tissues.
The total concentration of radioactivity in carcinoma tissue was significantly
greater than in muscle and was probably also greater than in skin and adipose
tissues.
The rates of incorporation of MeT and the rates of appearance of metabolites
of MeT in adipose and carcinoma tissues were similar.
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